These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 24927909)

  • 1. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.
    Bangalore S; Makani H; Radford M; Thakur K; Toklu B; Katz SD; DiNicolantonio JJ; Devereaux PJ; Alexander KP; Wetterslev J; Messerli FH
    Am J Med; 2014 Oct; 127(10):939-53. PubMed ID: 24927909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Beta-Blocker Therapy after Myocardial Infarction in the Reperfusion Era: A Systematic Review.
    Hong J; Barry AR
    Pharmacotherapy; 2018 May; 38(5):546-554. PubMed ID: 29601115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
    Park KL; Goldberg RJ; Anderson FA; López-Sendón J; Montalescot G; Brieger D; Eagle KA; Wyman A; Gore JM;
    Am J Med; 2014 Jun; 127(6):503-11. PubMed ID: 24561113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
    Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and outcomes associated with early heart failure pharmacotherapy in patients with ongoing cardiogenic shock.
    van Diepen S; Reynolds HR; Stebbins A; Lopes RD; Džavík V; Ruzyllo W; Geppert A; Widimsky P; Ohman EM; Parrillo JE; Dauerman HL; Baran DA; Hochman JS; Alexander JH
    Crit Care Med; 2014 Feb; 42(2):281-8. PubMed ID: 23982033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are beta-blockers effective in patients who develop heart failure soon after myocardial infarction? A meta-regression analysis of randomised trials.
    Houghton T; Freemantle N; Cleland JG
    Eur J Heart Fail; 2000 Sep; 2(3):333-40. PubMed ID: 10938496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
    Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
    Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
    Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
    Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
    Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
    Kristensen AMD; Bovin A; Zwisler AD; Cerquira C; Torp-Pedersen C; Bøtker HE; Gustafsson I; Veien KT; Thomsen KK; Olsen MH; Larsen ML; Nielsen OW; Hildebrandt P; Foghmar S; Jensen SE; Lange T; Sehested T; Jernberg T; Atar D; Ibanez B; Prescott E
    Trials; 2020 May; 21(1):415. PubMed ID: 32446298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Communitywide trends in the use and outcomes associated with beta-blockers in patients with acute myocardial infarction: the Worcester Heart Attack Study.
    Silvet H; Spencer F; Yarzebski J; Lessard D; Gore JM; Goldberg RJ
    Arch Intern Med; 2003 Oct; 163(18):2175-83. PubMed ID: 14557215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice.
    Viskin S; Kitzis I; Lev E; Zak Z; Heller K; Villa Y; Zajarias A; Laniado S; Belhassen B
    J Am Coll Cardiol; 1995 May; 25(6):1327-32. PubMed ID: 7722129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older emergency department patients with acute myocardial infarction receive lower quality of care than younger patients.
    Magid DJ; Masoudi FA; Vinson DR; van der Vlugt TM; Padgett TG; Tricomi AJ; Lyons EE; Crounse L; Brand DW; Go AS; Ho PM; Rumsfeld JS
    Ann Emerg Med; 2005 Jul; 46(1):14-21. PubMed ID: 15988420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era.
    Hu M; Hu S; Gao X; Yang Y
    Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143854
    [No Abstract]   [Full Text] [Related]  

  • 17. Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry.
    Juillière Y; Cambou JP; Bataille V; Mulak G; Galinier M; Gibelin P; Benamer H; Bouvaist H; Méneveau N; Tabone X; Simon T; Danchin N;
    Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):326-33. PubMed ID: 22357361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
    Halkin A; Grines CL; Cox DA; Garcia E; Mehran R; Tcheng JE; Griffin JJ; Guagliumi G; Brodie B; Turco M; Rutherford BD; Aymong E; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2004 May; 43(10):1780-7. PubMed ID: 15145099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
    Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
    Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.